Tango Therapeutics Inc (TNGX) — Cash Flow Reinvestment Rate

Latest as of September 2020: 0.63x

Tango Therapeutics Inc (TNGX) has a Cash Flow Reinvestment Rate of 0.63x as of September 2020, reinvesting $69.75 Million (capex $132.00K plus investments $-69.62 Million) from operating cash flow of $111.26 Million. Check earnings quality score of Tango Therapeutics Inc to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.63x

(Capex + Investments) / Operating CF

Total Reinvested

$69.75 Million

Capex + Investments

Operating Cash Flow

$111.26 Million

USD

Capital Expenditures

$132.00K

USD

Tango Therapeutics Inc Cash Flow Reinvestment Rate (2020–2020)

Historical reinvestment intensity for Tango Therapeutics Inc across 1 annual periods. Explore TNGX cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Tango Therapeutics Inc (2020–2020)

Year-by-year capital reinvestment analysis for Tango Therapeutics Inc. For live market cap and broader valuation context, see Tango Therapeutics Inc (TNGX) market capitalisation.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2020	2.08x	$145.43 Million	$70.07 Million	$1.11 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow